Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:55 AM
Ignite Modification Date:
2025-12-26 @ 1:35 AM
NCT ID:
NCT02734433
Pre Assignment Details:
The study was conducted in a dose-escalation 3 + 3 design and was comprised of 2 dose levels (Cohort 1 \[600 mg/day\] and Cohort 2 \[1000 mg/day\]). Selection of the pexidartinib dose of 1000 mg/day as the highest dose and the split-dose administration schedule was based on data from a Phase 1 study on patients with solid tumors (Study PLX108-01).
Recruitment Details:
A total of 12 participants who met all inclusion and no exclusion criteria were enrolled in the study; 11 participants were treated.
Study:
NCT02734433
Study Brief:
Results Section:
NCT02734433